Genexine Inc banner
G

Genexine Inc
KOSDAQ:095700

Watchlist Manager
Genexine Inc
KOSDAQ:095700
Watchlist
Price: 4 630 KRW 2.09% Market Closed
Market Cap: ₩210.9B

Wall Street
Price Targets

Price Targets Summary
Genexine Inc

There are no price targets for Genexine Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genexine Inc Competitors:
Price Targets
HCAT
Health Catalyst Inc
83% Upside
VERK
Verkkokauppa.com Oyj
38% Upside
ARDX
Ardelyx Inc
173% Upside
NSIT
Insight Enterprises Inc
58% Upside
FLB
Fluidigm Corp
71% Upside

Revenue
Forecast

4% / Year
Past Growth
805% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
4% / Year
Past Growth
805% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Genexine Inc's revenue is 4%. The projected CAGR for the next 1 year is 805%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Genexine Inc's stock price target?
Not Available

Genexine Inc doesn't have any price targets made by Wall Street professionals.

What is Genexine Inc's Revenue forecast?
Projected CAGR
805%

For the last 14 years the compound annual growth rate for Genexine Inc's revenue is 4%. The projected CAGR for the next 1 year is 805%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett